BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Garakani A, Murrough JW, Freire RC, Thom RP, Larkin K, Buono FD, Iosifescu DV. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Front Psychiatry 2020;11:595584. [PMID: 33424664 DOI: 10.3389/fpsyt.2020.595584] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Vallée A, Lecarpentier Y, Vallée JN. Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway. Mol Psychiatry 2021. [PMID: 33837269 DOI: 10.1038/s41380-021-01086-1] [Reference Citation Analysis]
2 Chen QH, Li YL, Hu YR, Liang WY, Zhang B. Observing time effect of SSRIs on suicide risk and suicide-related behaviour: a network meta-analysis protocol. BMJ Open 2021;11:e054479. [PMID: 34876436 DOI: 10.1136/bmjopen-2021-054479] [Reference Citation Analysis]
3 Liu C, Ying Z, Li Z, Zhang L, Li X, Gong W, Sun J, Fan X, Yang K, Wang X, Wei S, Dong N. Danzhi Xiaoyao Powder Promotes Neuronal Regeneration by Downregulating Notch Signaling Pathway in the Treatment of Generalized Anxiety Disorder. Front Pharmacol 2021;12:772576. [PMID: 34912225 DOI: 10.3389/fphar.2021.772576] [Reference Citation Analysis]
4 de F Cesário HPS, Silva FCO, Ferreira MKA, de Menezes JESA, Dos Santos HS, Nogueira CES, de L Silva KSB, Hajdu E, Silveira ER, Pessoa ODL. Anxiolytic-like effect of brominated compounds from the marine sponge Aplysina fulva on adult zebrafish (Danio rerio): Involvement of the GABAergic system. Neurochem Int 2021;146:105021. [PMID: 33741413 DOI: 10.1016/j.neuint.2021.105021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ortiz YT, Mcmahon LR, Wilkerson JL. Medicinal Cannabis and Central Nervous System Disorders. Front Pharmacol 2022;13:881810. [DOI: 10.3389/fphar.2022.881810] [Reference Citation Analysis]
6 Niu M, Gao Y, Yang M, Zhang Y, Geng J, Song Z, Chen Y, Li Y, Li J, Tian J. The quality and clinical applicability of recommendations in anxiety disorders guidelines: A systematic review of seventeen guidelines from seven countries. J Affect Disord 2021;295:1301-9. [PMID: 34706444 DOI: 10.1016/j.jad.2021.08.103] [Reference Citation Analysis]
7 Henry BJ. Symptom Management in Oncology: Depression and Anxiety. Seminars in Oncology Nursing 2022. [DOI: 10.1016/j.soncn.2022.151251] [Reference Citation Analysis]
8 Cui J, Li M, Wei Y, Li H, He X, Yang Q, Li Z, Duan J, Wu Z, Chen Q, Chen B, Li G, Ming X, Xiong L, Qin D. Inhalation Aromatherapy via Brain-Targeted Nasal Delivery: Natural Volatiles or Essential Oils on Mood Disorders. Front Pharmacol 2022;13:860043. [PMID: 35496310 DOI: 10.3389/fphar.2022.860043] [Reference Citation Analysis]
9 Shi R, Liu H, Tan P, Hu Z, Ma Y, Ye M, Gu Y, Wang Y, Ye T, Gu Y, Lu X, Huang C. Innate immune stimulation prevents the development of anxiety-like behaviors in chronically stressed mice. Neuropharmacology 2022;:108950. [PMID: 35074304 DOI: 10.1016/j.neuropharm.2022.108950] [Reference Citation Analysis]
10 Dominguez-Rodriguez A, Herdoiza-Arroyo PE, Martínez Arriaga RJ, Bautista Valerio E, Mateu Mollá J, de la Rosa-Gómez A, Farfallini L, Hernández Jiménez MJ, Esquivel Santoveña EE, Ramírez-Martínez FR, Castellanos Vargas RO, Arzola-Sánchez CA, Arenas-Landgrave P, Martínez-Luna SC. Prevalence of Anxiety Symptoms and Associated Clinical and Sociodemographic Factors in Mexican Adults Seeking Psychological Support for Grief During the COVID-19 Pandemic: A Cross-Sectional Study. Front Psychiatry 2022;13:749236. [PMID: 35370841 DOI: 10.3389/fpsyt.2022.749236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Rocha JL, Pires FQ, Gratieri T, Gelfuso GM, Sa-barreto LL, Cunha-filho M. Thermal analysis applied to the development of nanostructured lipid carriers loading propranolol using quality-by-design strategies. Thermochimica Acta 2022;708:179143. [DOI: 10.1016/j.tca.2021.179143] [Reference Citation Analysis]
12 Constable PA, Al-dasooqi D, Bruce R, Prem-senthil M. A Review of Ocular Complications Associated with Medications Used for Anxiety, Depression, and Stress. OPTO 2022;Volume 14:13-25. [DOI: 10.2147/opto.s355091] [Reference Citation Analysis]
13 Goodwin GM. Revisiting Treatment Options for Depressed Patients with Generalised Anxiety Disorder. Adv Ther 2021;38:61-8. [PMID: 34417993 DOI: 10.1007/s12325-021-01861-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Dos Santos RG, Osório FL, Rocha JM, Rossi GN, Bouso JC, Rodrigues LS, de Oliveira Silveira G, Yonamine M, Hallak JEC. Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder: A Pilot, Proof-of-Concept, Randomized, Placebo-Controlled Trial. J Clin Psychopharmacol 2021. [PMID: 34166299 DOI: 10.1097/JCP.0000000000001428] [Reference Citation Analysis]
15 Motti R, de Falco B. Traditional Herbal Remedies Used for Managing Anxiety and Insomnia in Italy: An Ethnopharmacological Overview. Horticulturae 2021;7:523. [DOI: 10.3390/horticulturae7120523] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Jovanović M, Petrović M, Cvijić S, Tomić N, Stojanović D, Ibrić S, Uskoković P. 3D Printed Buccal Films for Prolonged-Release of Propranolol Hydrochloride: Development, Characterization and Bioavailability Prediction. Pharmaceutics 2021;13:2143. [PMID: 34959423 DOI: 10.3390/pharmaceutics13122143] [Reference Citation Analysis]
17 Yan Y, Aierken A, Wang C, Jin W, Quan Z, Wang Z, Qing H, Ni J, Zhao J. Neuronal Circuits Associated with Fear Memory: Potential Therapeutic Targets for Posttraumatic Stress Disorder. Neuroscientist. [DOI: 10.1177/10738584211069977] [Reference Citation Analysis]
18 Casarrubea M, Di Giovanni G, Crescimanno G. Effects of Different Anxiety Levels on the Behavioral Patternings Investigated through T-pattern Analysis in Wistar Rats Tested in the Hole-Board Apparatus. Brain Sci 2021;11:714. [PMID: 34072001 DOI: 10.3390/brainsci11060714] [Reference Citation Analysis]
19 Lurati AR. Management of Obsessive Compulsive Symptoms in a Patient Diagnosed With Bipolar 1 Disorder and a History of Migraines. The Journal for Nurse Practitioners 2022. [DOI: 10.1016/j.nurpra.2022.01.009] [Reference Citation Analysis]
20 Schaefer M, Hellmann-Regen J, Enge S. Effects of Open-Label Placebos on State Anxiety and Glucocorticoid Stress Responses. Brain Sci 2021;11:508. [PMID: 33923694 DOI: 10.3390/brainsci11040508] [Reference Citation Analysis]
21 Akanji MA, Elijah OO, Oyedolapo AA, Aderonke AA, Opeoluwa OL, Omoloye AA, Oladoja FA, Olatundun SO, Edatomolaosi OL. Datura stramonium abrogates depression- and anxiety-like disorders in mice: possible involvement of monoaminergic pathways in its antidepressant activity. Drug Metab Pers Ther 2022. [PMID: 35218173 DOI: 10.1515/dmpt-2021-0166] [Reference Citation Analysis]
22 Stein DJ. Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine. Adv Ther 2021;38:52-60. [PMID: 34417992 DOI: 10.1007/s12325-021-01860-1] [Reference Citation Analysis]
23 Löscher W, Klein P. The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond. CNS Drugs 2021;35:935-63. [PMID: 34145528 DOI: 10.1007/s40263-021-00827-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Henriksson M, Wall A, Nyberg J, Adiels M, Lundin K, Bergh Y, Eggertsen R, Danielsson L, Kuhn HG, Westerlund M, David Åberg N, Waern M, Åberg M. Effects of exercise on symptoms of anxiety in primary care patients: A randomized controlled trial. J Affect Disord 2021;297:26-34. [PMID: 34644619 DOI: 10.1016/j.jad.2021.10.006] [Reference Citation Analysis]